Prevalence of and risk factors for peripheral arterial disease in Saudi Arabia. A pilot cross-sectional study

Saudi Medical Journal

Volumn 28, Issue 3, 2007, Pages 412-414

  Al Sheikh, Sultan O ^a   Aljabri, Badr A ^a   Al Ansary, Lubna A ^a   Al Khayal, Laila A ^a   Al Salman, Musaad M ^a   Al Omran, Mohammed A ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SAUDI ARABIA; SCREENING TEST; SMOKING; SYMPTOM;

AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PILOT PROJECTS; PREVALENCE; PRIMARY HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; ULTRASONOGRAPHY, DOPPLER;

EID: 34247260566     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982; 211: 249-256.
2. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978; 1: 1379-1381.
3. Imparato AM, Kim GE, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery 1975; 78: 795-799.
4. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992; 135: 331-340.
5. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13-18.
6. Criqui MH, Fronek A. Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-515.
7. Dormandy J, Mahir M, Ascady G, Balsano F, De Leeuw P, Blombery P, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989; 30: 50-57.
8. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981; 34: 261-269.
9. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-743.
10. The TASC Working Group. Managment of Peripheral Arterial Disease (PAD); Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2001; 31: S1-S288.
11. Criqui MH, Langer RD, Fronek A. Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326: 381-386.
12. Hirsch AT, Gloviczki P, Drooz A. Lovell M, Creager MA. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 2004; 39: 474-481.
13. Al-Zahrani HA. Al-Bar HM, Bahnassi A, Abdulaal AA. The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. Int Angiol 1997; 16: 123-128.
14. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109.
15. Feigelson HS, Criqui MH, Fronek A. Langer RD, Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemio1 l994; 140: 526-534.
16. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101: 16-22.
17. World Health Organization. WHO Statistical Information System (WHOSIS). Available from: URL: http://www3.who.int/whosis/life/ life_tables/